Special Spring 2026Preview: Lab automation & data sciences/AIOur journal edition “Lab Automation & Data Sciences/AI” for SLAS 2026 in Vienna. more ➔
Special Spring 2026Preview: Focus on PortugalThe biotech industry will meet in March 2026 at BIO-Europe Spring in Lisbon. This offers an excellent opportunity to shine a spotlight on biotechnology in Portugal. more ➔
Special Spring 2026Preview: CDMO Landscape EuropeThe special feature invites CDMO companies operating in Europe to showcase their expertise, platforms and value propositions. It offers a unique opportunity to present your company to an audience of … more ➔
Special Winter 2025Euro BioFairs CompassGuide to European Life Sciences Events in the first half year of 2026 more ➔
Special Autumn 2025CDMOs & CROsThe Trump administration’s trade policy has hit CDMOs and CROs hard. Trade barriers against Chinese service providers and raw material suppliers have increased biologics production costs and caused … more ➔
Special Summer 2025Euro BioFairs CompassGuide to Life Sciences Events in the second half year of 2025 more ➔
Special Summer 2025(Bio)EngineeringRegions and industry leaders are already preparing for the future. This Special spotlights emerging open innovation clusters and cutting-edge bioengineering platforms. more ➔
Special Spring 2025Oligonucleotides and PeptidesPeptide drugs recorded global sales in Europe. The market for gene and cell therapy contract manufacturing, oligonucleotide synthesis and the production of viral vectors and plasmids is also expanding … more ➔
Special Winter 2024Protein Engineering and ServicesMonoclonal antibodies still dominate the US$417bn biologics market. After decades of development, however, improved antibodies and protein formats with better target selectivity and safety profiles … more ➔
Special Autumn 2024CDMOs & CROsA draft US Biosecure Act being passed by the US House of Representatives and discussed by the US Senate could prohibit US biotech developers from collaborating with Chinese CROs, CDMOs and drug developers … more ➔
